1 Introduction to Research & Analysis Reports
1.1 Antisense Oligonucleotide Therapies Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Antisense Oligonucleotide Therapies Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Antisense Oligonucleotide Therapies Overall Market Size
2.1 Global Antisense Oligonucleotide Therapies Market Size: 2022 VS 2029
2.2 Global Antisense Oligonucleotide Therapies Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Antisense Oligonucleotide Therapies Players in Global Market
3.2 Top Global Antisense Oligonucleotide Therapies Companies Ranked by Revenue
3.3 Global Antisense Oligonucleotide Therapies Revenue by Companies
3.4 Top 3 and Top 5 Antisense Oligonucleotide Therapies Companies in Global Market, by Revenue in 2022
3.5 Global Companies Antisense Oligonucleotide Therapies Product Type
3.6 Tier 1, Tier 2 and Tier 3 Antisense Oligonucleotide Therapies Players in Global Market
3.6.1 List of Global Tier 1 Antisense Oligonucleotide Therapies Companies
3.6.2 List of Global Tier 2 and Tier 3 Antisense Oligonucleotide Therapies Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global Antisense Oligonucleotide Therapies Market Size Markets, 2022 & 2029
4.1.2 Without GalNAc-conjugated
4.1.3 With GalNAc-conjugated
4.2 By Type – Global Antisense Oligonucleotide Therapies Revenue & Forecasts
4.2.1 By Type – Global Antisense Oligonucleotide Therapies Revenue, 2018-2023
4.2.2 By Type – Global Antisense Oligonucleotide Therapies Revenue, 2024-2029
4.2.3 By Type – Global Antisense Oligonucleotide Therapies Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Antisense Oligonucleotide Therapies Market Size, 2022 & 2029
5.1.2 Genetic Disease
5.1.3 Cancer
5.1.4 Cardiovascular Diseases
5.1.5 Other
5.2 By Application – Global Antisense Oligonucleotide Therapies Revenue & Forecasts
5.2.1 By Application – Global Antisense Oligonucleotide Therapies Revenue, 2018-2023
5.2.2 By Application – Global Antisense Oligonucleotide Therapies Revenue, 2024-2029
5.2.3 By Application – Global Antisense Oligonucleotide Therapies Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global Antisense Oligonucleotide Therapies Market Size, 2022 & 2029
6.2 By Region – Global Antisense Oligonucleotide Therapies Revenue & Forecasts
6.2.1 By Region – Global Antisense Oligonucleotide Therapies Revenue, 2018-2023
6.2.2 By Region – Global Antisense Oligonucleotide Therapies Revenue, 2024-2029
6.2.3 By Region – Global Antisense Oligonucleotide Therapies Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America Antisense Oligonucleotide Therapies Revenue, 2018-2029
6.3.2 US Antisense Oligonucleotide Therapies Market Size, 2018-2029
6.3.3 Canada Antisense Oligonucleotide Therapies Market Size, 2018-2029
6.3.4 Mexico Antisense Oligonucleotide Therapies Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe Antisense Oligonucleotide Therapies Revenue, 2018-2029
6.4.2 Germany Antisense Oligonucleotide Therapies Market Size, 2018-2029
6.4.3 France Antisense Oligonucleotide Therapies Market Size, 2018-2029
6.4.4 U.K. Antisense Oligonucleotide Therapies Market Size, 2018-2029
6.4.5 Italy Antisense Oligonucleotide Therapies Market Size, 2018-2029
6.4.6 Russia Antisense Oligonucleotide Therapies Market Size, 2018-2029
6.4.7 Nordic Countries Antisense Oligonucleotide Therapies Market Size, 2018-2029
6.4.8 Benelux Antisense Oligonucleotide Therapies Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia Antisense Oligonucleotide Therapies Revenue, 2018-2029
6.5.2 China Antisense Oligonucleotide Therapies Market Size, 2018-2029
6.5.3 Japan Antisense Oligonucleotide Therapies Market Size, 2018-2029
6.5.4 South Korea Antisense Oligonucleotide Therapies Market Size, 2018-2029
6.5.5 Southeast Asia Antisense Oligonucleotide Therapies Market Size, 2018-2029
6.5.6 India Antisense Oligonucleotide Therapies Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America Antisense Oligonucleotide Therapies Revenue, 2018-2029
6.6.2 Brazil Antisense Oligonucleotide Therapies Market Size, 2018-2029
6.6.3 Argentina Antisense Oligonucleotide Therapies Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Antisense Oligonucleotide Therapies Revenue, 2018-2029
6.7.2 Turkey Antisense Oligonucleotide Therapies Market Size, 2018-2029
6.7.3 Israel Antisense Oligonucleotide Therapies Market Size, 2018-2029
6.7.4 Saudi Arabia Antisense Oligonucleotide Therapies Market Size, 2018-2029
6.7.5 UAE Antisense Oligonucleotide Therapies Market Size, 2018-2029
7 Antisense Oligonucleotide Therapies Companies Profiles
7.1 Ionis Pharmaceuticals
7.1.1 Ionis Pharmaceuticals Company Summary
7.1.2 Ionis Pharmaceuticals Business Overview
7.1.3 Ionis Pharmaceuticals Antisense Oligonucleotide Therapies Major Product Offerings
7.1.4 Ionis Pharmaceuticals Antisense Oligonucleotide Therapies Revenue in Global Market (2018-2023)
7.1.5 Ionis Pharmaceuticals Key News & Latest Developments
7.2 Sarepta Therapeutics
7.2.1 Sarepta Therapeutics Company Summary
7.2.2 Sarepta Therapeutics Business Overview
7.2.3 Sarepta Therapeutics Antisense Oligonucleotide Therapies Major Product Offerings
7.2.4 Sarepta Therapeutics Antisense Oligonucleotide Therapies Revenue in Global Market (2018-2023)
7.2.5 Sarepta Therapeutics Key News & Latest Developments
7.3 Nippon Shinyaku
7.3.1 Nippon Shinyaku Company Summary
7.3.2 Nippon Shinyaku Business Overview
7.3.3 Nippon Shinyaku Antisense Oligonucleotide Therapies Major Product Offerings
7.3.4 Nippon Shinyaku Antisense Oligonucleotide Therapies Revenue in Global Market (2018-2023)
7.3.5 Nippon Shinyaku Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
Table 1. Antisense Oligonucleotide Therapies Market Opportunities & Trends in Global Market
Table 2. Antisense Oligonucleotide Therapies Market Drivers in Global Market
Table 3. Antisense Oligonucleotide Therapies Market Restraints in Global Market
Table 4. Key Players of Antisense Oligonucleotide Therapies in Global Market
Table 5. Top Antisense Oligonucleotide Therapies Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Antisense Oligonucleotide Therapies Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Antisense Oligonucleotide Therapies Revenue Share by Companies, 2018-2023
Table 8. Global Companies Antisense Oligonucleotide Therapies Product Type
Table 9. List of Global Tier 1 Antisense Oligonucleotide Therapies Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Antisense Oligonucleotide Therapies Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Antisense Oligonucleotide Therapies Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Antisense Oligonucleotide Therapies Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Antisense Oligonucleotide Therapies Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application – Global Antisense Oligonucleotide Therapies Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Antisense Oligonucleotide Therapies Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Antisense Oligonucleotide Therapies Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region – Global Antisense Oligonucleotide Therapies Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Antisense Oligonucleotide Therapies Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Antisense Oligonucleotide Therapies Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Antisense Oligonucleotide Therapies Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Antisense Oligonucleotide Therapies Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Antisense Oligonucleotide Therapies Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Antisense Oligonucleotide Therapies Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Antisense Oligonucleotide Therapies Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Antisense Oligonucleotide Therapies Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Antisense Oligonucleotide Therapies Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Antisense Oligonucleotide Therapies Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Antisense Oligonucleotide Therapies Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Antisense Oligonucleotide Therapies Revenue, (US$, Mn), 2024-2029
Table 30. Ionis Pharmaceuticals Company Summary
Table 31. Ionis Pharmaceuticals Antisense Oligonucleotide Therapies Product Offerings
Table 32. Ionis Pharmaceuticals Antisense Oligonucleotide Therapies Revenue (US$, Mn) & (2018-2023)
Table 33. Ionis Pharmaceuticals Key News & Latest Developments
Table 34. Sarepta Therapeutics Company Summary
Table 35. Sarepta Therapeutics Antisense Oligonucleotide Therapies Product Offerings
Table 36. Sarepta Therapeutics Antisense Oligonucleotide Therapies Revenue (US$, Mn) & (2018-2023)
Table 37. Sarepta Therapeutics Key News & Latest Developments
Table 38. Nippon Shinyaku Company Summary
Table 39. Nippon Shinyaku Antisense Oligonucleotide Therapies Product Offerings
Table 40. Nippon Shinyaku Antisense Oligonucleotide Therapies Revenue (US$, Mn) & (2018-2023)
Table 41. Nippon Shinyaku Key News & Latest Developments
List of Figures
Figure 1. Antisense Oligonucleotide Therapies Segment by Type in 2022
Figure 2. Antisense Oligonucleotide Therapies Segment by Application in 2022
Figure 3. Global Antisense Oligonucleotide Therapies Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Antisense Oligonucleotide Therapies Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Antisense Oligonucleotide Therapies Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Antisense Oligonucleotide Therapies Revenue in 2022
Figure 8. By Type - Global Antisense Oligonucleotide Therapies Revenue Market Share, 2018-2029
Figure 9. By Application - Global Antisense Oligonucleotide Therapies Revenue Market Share, 2018-2029
Figure 10. By Type - Global Antisense Oligonucleotide Therapies Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Antisense Oligonucleotide Therapies Revenue Market Share, 2018-2029
Figure 12. By Application - Global Antisense Oligonucleotide Therapies Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Antisense Oligonucleotide Therapies Revenue Market Share, 2018-2029
Figure 14. By Region - Global Antisense Oligonucleotide Therapies Revenue Market Share, 2018-2029
Figure 15. By Country - North America Antisense Oligonucleotide Therapies Revenue Market Share, 2018-2029
Figure 16. US Antisense Oligonucleotide Therapies Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Antisense Oligonucleotide Therapies Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Antisense Oligonucleotide Therapies Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Antisense Oligonucleotide Therapies Revenue Market Share, 2018-2029
Figure 20. Germany Antisense Oligonucleotide Therapies Revenue, (US$, Mn), 2018-2029
Figure 21. France Antisense Oligonucleotide Therapies Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Antisense Oligonucleotide Therapies Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Antisense Oligonucleotide Therapies Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Antisense Oligonucleotide Therapies Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Antisense Oligonucleotide Therapies Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Antisense Oligonucleotide Therapies Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Antisense Oligonucleotide Therapies Revenue Market Share, 2018-2029
Figure 28. China Antisense Oligonucleotide Therapies Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Antisense Oligonucleotide Therapies Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Antisense Oligonucleotide Therapies Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Antisense Oligonucleotide Therapies Revenue, (US$, Mn), 2018-2029
Figure 32. India Antisense Oligonucleotide Therapies Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Antisense Oligonucleotide Therapies Revenue Market Share, 2018-2029
Figure 34. Brazil Antisense Oligonucleotide Therapies Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Antisense Oligonucleotide Therapies Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Antisense Oligonucleotide Therapies Revenue Market Share, 2018-2029
Figure 37. Turkey Antisense Oligonucleotide Therapies Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Antisense Oligonucleotide Therapies Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Antisense Oligonucleotide Therapies Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Antisense Oligonucleotide Therapies Revenue, (US$, Mn), 2018-2029
Figure 41. Ionis Pharmaceuticals Antisense Oligonucleotide Therapies Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Sarepta Therapeutics Antisense Oligonucleotide Therapies Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Nippon Shinyaku Antisense Oligonucleotide Therapies Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
